Orphenadrine Extended-Release Tablets and Ramucirumab Intravenous
Determining the interaction of Orphenadrine Extended-Release Tablets and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Ranexa
- Orphenadrine Extended-Release Tablets-Ranibizumab
- Orphenadrine Extended-Release Tablets-Ranibizumab Intraocular
- Orphenadrine Extended-Release Tablets-Ranibizumab ophthalmic
- Orphenadrine Extended-Release Tablets-Ranitidine
- Orphenadrine Extended-Release Tablets-Ranitidine Capsule
- Ramucirumab Intravenous-Orphenadrine Injection
- Ramucirumab Intravenous-Orphenadrine w/A.C.
- Ramucirumab Intravenous-Orphenadrine, aspirin, and caffeine
- Ramucirumab Intravenous-Orphenate
- Ramucirumab Intravenous-Orphengesic
- Ramucirumab Intravenous-Orphengesic Forte